Association between serum autotaxin or phosphatidylserine‐specific phospholipase A1 levels and melanoma
Autotaxin (ATX), a producing enzyme for lysophosphatidic acids, was first identified from the medium of a melanoma cell line and has been considered to be one of the candidate targets to treat melanoma; however, the association between serum ATX and melanoma in human subjects has not been elucidated...
Saved in:
| Published in | Journal of dermatology Vol. 45; no. 5; pp. 571 - 579 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Wiley Subscription Services, Inc
01.05.2018
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0385-2407 1346-8138 1346-8138 |
| DOI | 10.1111/1346-8138.14278 |
Cover
| Abstract | Autotaxin (ATX), a producing enzyme for lysophosphatidic acids, was first identified from the medium of a melanoma cell line and has been considered to be one of the candidate targets to treat melanoma; however, the association between serum ATX and melanoma in human subjects has not been elucidated. Along with ATX, phosphatidylserine‐specific phospholipase A1 (PS‐PLA1) is a producing enzyme for lysophosphatidylserine, a similar glycero‐lysophospholipid mediator to lysophosphatidic acids. In the present study, we aimed to investigate the association between serum ATX or PS‐PLA1 levels and melanoma. We measured the serum levels of ATX, ATX isoforms and PS‐PLA1 in subjects with melanoma (n = 57) and healthy subjects (n = 58). We further investigated the existence of trends according to the clinical stages of melanoma. We observed that serum total ATX and classical ATX levels were significant higher and serum novel ATX levels tended to be higher in male subjects with melanoma, while no significant difference was observed between the two groups in female subjects. The trend test revealed that the serum total ATX and ATX isoforms were significantly associated with the clinical stages of female subjects with melanoma. Regarding PS‐PLA1, serum PS‐PLA1 levels were significantly higher in the melanoma subjects and associated with the clinical stages. The present study is the first study which revealed the association between ATX or PS‐PLA1 and melanoma, suggesting the possible involvement of ATX/lysophosphatidic acids or PS‐PLA1/lysophosphatidylserine axis in the pathogenesis of melanoma. |
|---|---|
| AbstractList | Autotaxin (ATX), a producing enzyme for lysophosphatidic acids, was first identified from the medium of a melanoma cell line and has been considered to be one of the candidate targets to treat melanoma; however, the association between serum ATX and melanoma in human subjects has not been elucidated. Along with ATX, phosphatidylserine-specific phospholipase A1 (PS-PLA
) is a producing enzyme for lysophosphatidylserine, a similar glycero-lysophospholipid mediator to lysophosphatidic acids. In the present study, we aimed to investigate the association between serum ATX or PS-PLA
levels and melanoma. We measured the serum levels of ATX, ATX isoforms and PS-PLA
in subjects with melanoma (n = 57) and healthy subjects (n = 58). We further investigated the existence of trends according to the clinical stages of melanoma. We observed that serum total ATX and classical ATX levels were significant higher and serum novel ATX levels tended to be higher in male subjects with melanoma, while no significant difference was observed between the two groups in female subjects. The trend test revealed that the serum total ATX and ATX isoforms were significantly associated with the clinical stages of female subjects with melanoma. Regarding PS-PLA
, serum PS-PLA
levels were significantly higher in the melanoma subjects and associated with the clinical stages. The present study is the first study which revealed the association between ATX or PS-PLA
and melanoma, suggesting the possible involvement of ATX/lysophosphatidic acids or PS-PLA
/lysophosphatidylserine axis in the pathogenesis of melanoma. Autotaxin ( ATX ), a producing enzyme for lysophosphatidic acids, was first identified from the medium of a melanoma cell line and has been considered to be one of the candidate targets to treat melanoma; however, the association between serum ATX and melanoma in human subjects has not been elucidated. Along with ATX , phosphatidylserine‐specific phospholipase A1 ( PS ‐ PLA 1 ) is a producing enzyme for lysophosphatidylserine, a similar glycero‐lysophospholipid mediator to lysophosphatidic acids. In the present study, we aimed to investigate the association between serum ATX or PS ‐ PLA 1 levels and melanoma. We measured the serum levels of ATX , ATX isoforms and PS ‐ PLA 1 in subjects with melanoma ( n = 57) and healthy subjects ( n = 58). We further investigated the existence of trends according to the clinical stages of melanoma. We observed that serum total ATX and classical ATX levels were significant higher and serum novel ATX levels tended to be higher in male subjects with melanoma, while no significant difference was observed between the two groups in female subjects. The trend test revealed that the serum total ATX and ATX isoforms were significantly associated with the clinical stages of female subjects with melanoma. Regarding PS ‐ PLA 1 , serum PS ‐ PLA 1 levels were significantly higher in the melanoma subjects and associated with the clinical stages. The present study is the first study which revealed the association between ATX or PS ‐ PLA 1 and melanoma, suggesting the possible involvement of ATX /lysophosphatidic acids or PS ‐ PLA 1 /lysophosphatidylserine axis in the pathogenesis of melanoma. Autotaxin (ATX), a producing enzyme for lysophosphatidic acids, was first identified from the medium of a melanoma cell line and has been considered to be one of the candidate targets to treat melanoma; however, the association between serum ATX and melanoma in human subjects has not been elucidated. Along with ATX, phosphatidylserine‐specific phospholipase A1 (PS‐PLA1) is a producing enzyme for lysophosphatidylserine, a similar glycero‐lysophospholipid mediator to lysophosphatidic acids. In the present study, we aimed to investigate the association between serum ATX or PS‐PLA1 levels and melanoma. We measured the serum levels of ATX, ATX isoforms and PS‐PLA1 in subjects with melanoma (n = 57) and healthy subjects (n = 58). We further investigated the existence of trends according to the clinical stages of melanoma. We observed that serum total ATX and classical ATX levels were significant higher and serum novel ATX levels tended to be higher in male subjects with melanoma, while no significant difference was observed between the two groups in female subjects. The trend test revealed that the serum total ATX and ATX isoforms were significantly associated with the clinical stages of female subjects with melanoma. Regarding PS‐PLA1, serum PS‐PLA1 levels were significantly higher in the melanoma subjects and associated with the clinical stages. The present study is the first study which revealed the association between ATX or PS‐PLA1 and melanoma, suggesting the possible involvement of ATX/lysophosphatidic acids or PS‐PLA1/lysophosphatidylserine axis in the pathogenesis of melanoma. Autotaxin (ATX), a producing enzyme for lysophosphatidic acids, was first identified from the medium of a melanoma cell line and has been considered to be one of the candidate targets to treat melanoma; however, the association between serum ATX and melanoma in human subjects has not been elucidated. Along with ATX, phosphatidylserine-specific phospholipase A1 (PS-PLA1 ) is a producing enzyme for lysophosphatidylserine, a similar glycero-lysophospholipid mediator to lysophosphatidic acids. In the present study, we aimed to investigate the association between serum ATX or PS-PLA1 levels and melanoma. We measured the serum levels of ATX, ATX isoforms and PS-PLA1 in subjects with melanoma (n = 57) and healthy subjects (n = 58). We further investigated the existence of trends according to the clinical stages of melanoma. We observed that serum total ATX and classical ATX levels were significant higher and serum novel ATX levels tended to be higher in male subjects with melanoma, while no significant difference was observed between the two groups in female subjects. The trend test revealed that the serum total ATX and ATX isoforms were significantly associated with the clinical stages of female subjects with melanoma. Regarding PS-PLA1 , serum PS-PLA1 levels were significantly higher in the melanoma subjects and associated with the clinical stages. The present study is the first study which revealed the association between ATX or PS-PLA1 and melanoma, suggesting the possible involvement of ATX/lysophosphatidic acids or PS-PLA1 /lysophosphatidylserine axis in the pathogenesis of melanoma.Autotaxin (ATX), a producing enzyme for lysophosphatidic acids, was first identified from the medium of a melanoma cell line and has been considered to be one of the candidate targets to treat melanoma; however, the association between serum ATX and melanoma in human subjects has not been elucidated. Along with ATX, phosphatidylserine-specific phospholipase A1 (PS-PLA1 ) is a producing enzyme for lysophosphatidylserine, a similar glycero-lysophospholipid mediator to lysophosphatidic acids. In the present study, we aimed to investigate the association between serum ATX or PS-PLA1 levels and melanoma. We measured the serum levels of ATX, ATX isoforms and PS-PLA1 in subjects with melanoma (n = 57) and healthy subjects (n = 58). We further investigated the existence of trends according to the clinical stages of melanoma. We observed that serum total ATX and classical ATX levels were significant higher and serum novel ATX levels tended to be higher in male subjects with melanoma, while no significant difference was observed between the two groups in female subjects. The trend test revealed that the serum total ATX and ATX isoforms were significantly associated with the clinical stages of female subjects with melanoma. Regarding PS-PLA1 , serum PS-PLA1 levels were significantly higher in the melanoma subjects and associated with the clinical stages. The present study is the first study which revealed the association between ATX or PS-PLA1 and melanoma, suggesting the possible involvement of ATX/lysophosphatidic acids or PS-PLA1 /lysophosphatidylserine axis in the pathogenesis of melanoma. |
| Author | Miyagaki, Tomomitsu Kurano, Makoto Yatomi, Yutaka Igarashi, Koji Ikeda, Hitoshi Sato, Shinichi Miyagawa, Takuya Shimamoto, Satoshi Aoki, Junken |
| Author_xml | – sequence: 1 givenname: Makoto orcidid: 0000-0002-2596-1145 surname: Kurano fullname: Kurano, Makoto email: kurano-tky@umin.ac.jp organization: The University of Tokyo – sequence: 2 givenname: Tomomitsu orcidid: 0000-0003-1879-3128 surname: Miyagaki fullname: Miyagaki, Tomomitsu organization: The University of Tokyo – sequence: 3 givenname: Takuya surname: Miyagawa fullname: Miyagawa, Takuya organization: The University of Tokyo – sequence: 4 givenname: Koji surname: Igarashi fullname: Igarashi, Koji organization: TOSOH Corporation – sequence: 5 givenname: Satoshi surname: Shimamoto fullname: Shimamoto, Satoshi organization: TOSOH Corporation – sequence: 6 givenname: Hitoshi surname: Ikeda fullname: Ikeda, Hitoshi organization: The University of Tokyo – sequence: 7 givenname: Junken surname: Aoki fullname: Aoki, Junken organization: Tohoku University – sequence: 8 givenname: Shinichi surname: Sato fullname: Sato, Shinichi organization: The University of Tokyo – sequence: 9 givenname: Yutaka surname: Yatomi fullname: Yatomi, Yutaka email: yatoyuta-tky@umin.ac.jp organization: The University of Tokyo |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29500864$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkb9OHDEQxi0EguOSOl1kKU2aBf9br7c8EUiCkGigtny-sTDatRd7F3JdHiHPmCfBxx0pkFDcjOT5fd-M5jtG-yEGQOgTJSe0vFPKhawU5eqECtaoPTT797OPZoSrumKCNEfoOOd7QlhbU3KIjkolREkxQ36Rc7TejD4GvITxCSDgDGnqsZnGOJpfPuCY8HAX83BXsNW6K20f4O_vP3kA6523u27s_GAy4AXFHTxCl7EJK9xDZ0LszQd04EzRftzVObq9OL85-1FdXX__eba4qqyQVFVghWgUlRwUNGAEV47VzC0dY6xxhNRK8JWTLVXguGKiXTonueRt27RgieNz9HXrO6T4MEEede-zha5sAXHKmhFKeMN58ZmjL2_Q-zilULYrFCc1k5KwQn3eUdOyh5Ueku9NWuvXIxag3gI2xZwTOG39-HLRMRnfaUr0Jiy9iUZvotEvYRXd6Rvdq_X7it2kJ9_B-n-4vvx2vtU9A1X2pWU |
| CitedBy_id | crossref_primary_10_1177_09612033221128494 crossref_primary_10_1038_s41598_021_85595_7 crossref_primary_10_1111_1756_185X_13689 crossref_primary_10_1016_j_tranon_2021_101237 crossref_primary_10_1507_endocrj_EJ18_0451 crossref_primary_10_2183_pjab_94_025 crossref_primary_10_1007_s10555_018_9729_x crossref_primary_10_1248_bpb_b22_00001 crossref_primary_10_1016_j_plipres_2021_101112 crossref_primary_10_3390_ijms24086986 crossref_primary_10_1016_j_cca_2020_01_011 crossref_primary_10_1016_j_pharmthera_2023_108415 crossref_primary_10_1016_j_cca_2020_06_019 crossref_primary_10_1111_1744_9987_14211 crossref_primary_10_1016_j_plipres_2020_101068 crossref_primary_10_1038_s41598_020_59590_3 crossref_primary_10_1038_s41598_022_08388_6 crossref_primary_10_1111_1756_185X_14031 crossref_primary_10_14712_fb2023069050149 crossref_primary_10_1177_0004563218818197 crossref_primary_10_3390_ijms222312685 |
| Cites_doi | 10.1016/j.prostaglandins.2009.04.009 10.1016/j.bbacli.2015.08.003 10.1158/1541-7786.MCR-14-0263 10.4061/2011/194857 10.1111/j.1365-2141.2008.07325.x 10.1016/0014-5793(93)81724-E 10.1016/j.bbagen.2016.11.032 10.1093/jb/mvr126 10.1038/nrc1143 10.1074/jbc.M111.276725 10.1194/jlr.P072090 10.1084/jem.20141827 10.1016/S0014-5793(97)00098-7 10.1016/j.yexcr.2014.11.010 10.1021/acs.jmedchem.6b01270 10.1038/nmeth.2172 10.1186/1476-4598-9-140 10.1006/bbrc.1996.0127 10.1194/jlr.P071803 10.1016/S1388-1981(02)00134-8 10.1007/s10555-011-9319-7 10.1016/j.canlet.2014.10.001 10.1038/nsmb.1980 10.1074/jbc.274.16.11053 10.1016/S0021-9258(18)45911-X 10.5551/jat.25650 10.1371/journal.pone.0130074 10.1016/j.cca.2007.10.005 10.1093/jb/mvu077 10.1023/A:1020950420196 10.1136/bjo.2007.116947 10.1074/jbc.M206812200 10.1083/jcb.200204026 10.1016/j.cca.2010.04.006 10.1016/j.bbalip.2012.08.015 |
| ContentType | Journal Article |
| Copyright | 2018 Japanese Dermatological Association 2018 Japanese Dermatological Association. Copyright © 2018 Japanese Dermatological Association |
| Copyright_xml | – notice: 2018 Japanese Dermatological Association – notice: 2018 Japanese Dermatological Association. – notice: Copyright © 2018 Japanese Dermatological Association |
| DBID | AAYXX CITATION NPM 7T5 H94 K9. 7X8 |
| DOI | 10.1111/1346-8138.14278 |
| DatabaseName | CrossRef PubMed Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts MEDLINE - Academic |
| DatabaseTitleList | PubMed CrossRef AIDS and Cancer Research Abstracts MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1346-8138 |
| EndPage | 579 |
| ExternalDocumentID | 29500864 10_1111_1346_8138_14278 JDE14278 |
| Genre | article Journal Article |
| GrantInformation_xml | – fundername: JST/AMED – fundername: AMED – fundername: JSPS funderid: 16H06236 |
| GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 123 1OB 1OC 29K 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANHP AANLZ AAONW AAQQT AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFFNX AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHMBA AIACR AIDQK AIDYY AIQQE AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB B.R BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 CYRXZ D-6 D-7 D-E D-F D-I DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMB EMOBN EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO ROL RX1 SAMSI SJN SUPJJ SV3 TEORI UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WVDHM WXI WXSBR X7M XG1 ZZTAW ~IA ~WT AAYXX CITATION AAHHS ACCFJ AEEZP AEQDE AEUQT AFPWT AIWBW AJBDE NPM WRC 7T5 H94 K9. 7X8 |
| ID | FETCH-LOGICAL-c4618-ec4478163e8e7ea438f252fbf2227f005843df6918ef38249bff63639979ec0f3 |
| IEDL.DBID | DR2 |
| ISSN | 0385-2407 1346-8138 |
| IngestDate | Fri Sep 05 09:01:12 EDT 2025 Tue Oct 07 05:57:01 EDT 2025 Wed Feb 19 02:43:30 EST 2025 Thu Apr 24 22:54:53 EDT 2025 Wed Oct 01 03:43:53 EDT 2025 Thu Sep 25 07:35:38 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | lysophosphatidylserine lysophosphatidic acids melanoma phosphatidylserine-specific phospholipase A1 autotaxin |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2018 Japanese Dermatological Association. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4618-ec4478163e8e7ea438f252fbf2227f005843df6918ef38249bff63639979ec0f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0000-0003-1879-3128 0000-0002-2596-1145 |
| PMID | 29500864 |
| PQID | 2030526602 |
| PQPubID | 1006353 |
| PageCount | 9 |
| ParticipantIDs | proquest_miscellaneous_2010373384 proquest_journals_2030526602 pubmed_primary_29500864 crossref_citationtrail_10_1111_1346_8138_14278 crossref_primary_10_1111_1346_8138_14278 wiley_primary_10_1111_1346_8138_14278_JDE14278 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | May 2018 |
| PublicationDateYYYYMMDD | 2018-05-01 |
| PublicationDate_xml | – month: 05 year: 2018 text: May 2018 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Tokyo |
| PublicationTitle | Journal of dermatology |
| PublicationTitleAlternate | J Dermatol |
| PublicationYear | 2018 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2015; 13 2009; 89 2013; 1831 2017; 60 2015; 4 2002; 19 2002; 1582 2002; 158 1992; 267 2017; 1861 2002; 277 2015; 10 2011; 30 2007; 91 2008; 388 2008; 143 2011; 18 2011; 2011 2012; 151 1993; 316 1997; 404 2017; 58 2015; 157 2015; 356 2015; 333 2015; 212 2010; 411 1997; 57 2015; 22 1999; 274 2003; 3 1996; 218 2010; 9 2011; 286 2012; 9 e_1_2_10_23_1 e_1_2_10_24_1 e_1_2_10_21_1 e_1_2_10_22_1 e_1_2_10_20_1 e_1_2_10_2_1 e_1_2_10_4_1 e_1_2_10_18_1 e_1_2_10_3_1 e_1_2_10_19_1 e_1_2_10_6_1 e_1_2_10_16_1 e_1_2_10_5_1 e_1_2_10_17_1 e_1_2_10_8_1 e_1_2_10_14_1 e_1_2_10_37_1 e_1_2_10_7_1 e_1_2_10_15_1 e_1_2_10_36_1 Kawagoe H (e_1_2_10_10_1) 1997; 57 e_1_2_10_12_1 e_1_2_10_35_1 e_1_2_10_9_1 e_1_2_10_13_1 e_1_2_10_34_1 e_1_2_10_33_1 e_1_2_10_11_1 e_1_2_10_32_1 e_1_2_10_31_1 e_1_2_10_30_1 e_1_2_10_29_1 e_1_2_10_27_1 e_1_2_10_28_1 e_1_2_10_25_1 e_1_2_10_26_1 |
| References_xml | – volume: 1831 start-page: 74 year: 2013 end-page: 85 article-title: Role of the autotaxin‐lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy publication-title: Biochim Biophys Acta – volume: 60 start-page: 1309 year: 2017 end-page: 1324 article-title: Highly potent non‐carboxylic acid autotaxin inhibitors reduce melanoma metastasis and chemotherapeutic resistance of breast cancer stem cells publication-title: J Med Chem – volume: 58 start-page: 433 year: 2017 end-page: 442 article-title: Different origins of lysophospholipid mediators between coronary and peripheral arteries in acute coronary syndrome publication-title: J Lipid Res – volume: 19 start-page: 603 year: 2002 end-page: 608 article-title: Expression of autotaxin (npp‐2) is closely linked to invasiveness of breast cancer cells publication-title: Clin Exp Metastasis – volume: 57 start-page: 2516 year: 1997 end-page: 2521 article-title: Expression and transcriptional regulation of the pd‐ialpha/autotaxin gene in neuroblastoma publication-title: Cancer Res – volume: 13 start-page: 174 year: 2015 end-page: 185 article-title: Autotaxin and lpa1 and lpa5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasis publication-title: Mol Cancer Res – volume: 158 start-page: 227 year: 2002 end-page: 233 article-title: Autotaxin has lysophospholipase d activity leading to tumor cell growth and motility by lysophosphatidic acid production publication-title: J Cell Biol – volume: 4 start-page: 92 year: 2015 end-page: 98 article-title: Blood levels of serotonin are specifically correlated with plasma lysophosphatidylserine among the glycero‐lysophospholipids publication-title: BBA Clin – volume: 388 start-page: 51 year: 2008 end-page: 58 article-title: Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation publication-title: Clin Chim Acta – volume: 151 start-page: 89 year: 2012 end-page: 97 article-title: Identification and biochemical characterization of a novel autotaxin isoform, atxdelta, with a four‐amino acid deletion publication-title: J Biochem – volume: 267 start-page: 2524 year: 1992 end-page: 2529 article-title: Identification, purification, and partial sequence analysis of autotaxin, a novel motility‐stimulating protein publication-title: J Biol Chem – volume: 3 start-page: 582 year: 2003 end-page: 591 article-title: The emerging role of lysophosphatidic acid in cancer publication-title: Nat Rev Cancer – volume: 277 start-page: 48737 year: 2002 end-page: 48744 article-title: Serum lysophosphatidic acid is produced through diverse phospholipase pathways publication-title: J Biol Chem – volume: 404 start-page: 82 year: 1997 end-page: 86 article-title: Nmd, a novel gene differentially expressed in human melanoma cell lines, encodes a new atypical member of the enzyme family of lipases publication-title: FEBS Lett – volume: 274 start-page: 11053 year: 1999 end-page: 11059 article-title: An alternative splicing form of phosphatidylserine‐specific phospholipase a1 that exhibits lysophosphatidylserine‐specific lysophospholipase activity in humans publication-title: J Biol Chem – volume: 316 start-page: 1 year: 1993 end-page: 4 article-title: Role of a serum phospholipase a1 in the phosphatidylserine‐induced t cell inhibition publication-title: FEBS Lett – volume: 212 start-page: 1011 year: 2015 end-page: 1020 article-title: The lysophosphatidylserine receptor gpr174 constrains regulatory t cell development and function publication-title: J Exp Med – volume: 1861 start-page: 256 year: 2017 end-page: 263 article-title: A rhodium(iii)‐based inhibitor of autotaxin with antiproliferative activity publication-title: Biochim Biophys Acta – volume: 143 start-page: 60 year: 2008 end-page: 70 article-title: Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma publication-title: Br J Haematol – volume: 9 start-page: 140 year: 2010 article-title: Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid publication-title: Mol Cancer – volume: 58 start-page: 763 year: 2017 end-page: 771 article-title: Analysis of glycero‐lysophospholipids in gastric cancerous ascites publication-title: J Lipid Res – volume: 10 start-page: e0130074 year: 2015 article-title: A new enzyme immunoassay for the quantitative determination of classical autotaxins (atxalpha, atxbeta, and atxgamma) and novel autotaxins (atxdelta and atxepsilon) publication-title: PLoS One – volume: 157 start-page: 81 year: 2015 end-page: 89 article-title: Lysophosphatidic acid as a lipid mediator with multiple biological actions publication-title: J Biochem – volume: 89 start-page: 135 year: 2009 end-page: 139 article-title: Emerging lysophospholipid mediators, lysophosphatidylserine, lysophosphatidylthreonine, lysophosphatidylethanolamine and lysophosphatidylglycerol publication-title: Prostaglandins Other Lipid Mediat – volume: 286 start-page: 34654 year: 2011 end-page: 34663 article-title: Binding of autotaxin to integrins localizes lysophosphatidic acid production to platelets and mammalian cells publication-title: J Biol Chem – volume: 30 start-page: 557 year: 2011 end-page: 565 article-title: Autotaxin and lpa receptor signaling in cancer publication-title: Cancer Metastasis Rev – volume: 9 start-page: 1021 year: 2012 end-page: 1029 article-title: Tgfalpha shedding assay: an accurate and versatile method for detecting gpcr activation publication-title: Nat Methods – volume: 411 start-page: 1090 year: 2010 end-page: 1094 article-title: A novel enzyme immunoassay for the determination of phosphatidylserine‐specific phospholipase a(1) in human serum samples publication-title: Clin Chim Acta – volume: 2011 start-page: 194857 year: 2011 article-title: Autotaxin: its role in biology of melanoma cells and as a pharmacological target publication-title: Enzyme Res – volume: 18 start-page: 198 year: 2011 end-page: 204 article-title: Structural basis of substrate discrimination and integrin binding by autotaxin publication-title: Nat Struct Mol Biol – volume: 356 start-page: 589 year: 2015 end-page: 596 article-title: The src homology 3 binding domain is required for lysophosphatidic acid 3 receptor‐mediated cellular viability in melanoma cells publication-title: Cancer Lett – volume: 218 start-page: 714 year: 1996 end-page: 719 article-title: Cloning, chromosomal localization, and tissue expression of autotaxin from human teratocarcinoma cells publication-title: Biochem Biophys Res Commun – volume: 22 start-page: 518 year: 2015 end-page: 526 article-title: Lysophosphatidylserine has bilateral effects on macrophages in the pathogenesis of atherosclerosis publication-title: J Atheroscler Thromb – volume: 91 start-page: 1385 year: 2007 end-page: 1392 article-title: Reduced expression of autotaxin predicts survival in uveal melanoma publication-title: Br J Ophthalmol – volume: 333 start-page: 183 year: 2015 end-page: 189 article-title: New insights into the autotaxin/lpa axis in cancer development and metastasis publication-title: Exp Cell Res – volume: 1582 start-page: 26 year: 2002 end-page: 32 article-title: Structure and function of phosphatidylserine‐specific phospholipase a1 publication-title: Biochim Biophys Acta – ident: e_1_2_10_21_1 doi: 10.1016/j.prostaglandins.2009.04.009 – ident: e_1_2_10_33_1 doi: 10.1016/j.bbacli.2015.08.003 – ident: e_1_2_10_12_1 doi: 10.1158/1541-7786.MCR-14-0263 – ident: e_1_2_10_15_1 doi: 10.4061/2011/194857 – ident: e_1_2_10_11_1 doi: 10.1111/j.1365-2141.2008.07325.x – ident: e_1_2_10_35_1 doi: 10.1016/0014-5793(93)81724-E – ident: e_1_2_10_17_1 doi: 10.1016/j.bbagen.2016.11.032 – ident: e_1_2_10_30_1 doi: 10.1093/jb/mvr126 – ident: e_1_2_10_5_1 doi: 10.1038/nrc1143 – ident: e_1_2_10_32_1 doi: 10.1074/jbc.M111.276725 – ident: e_1_2_10_23_1 doi: 10.1194/jlr.P072090 – ident: e_1_2_10_37_1 doi: 10.1084/jem.20141827 – ident: e_1_2_10_24_1 doi: 10.1016/S0014-5793(97)00098-7 – ident: e_1_2_10_8_1 doi: 10.1016/j.yexcr.2014.11.010 – ident: e_1_2_10_16_1 doi: 10.1021/acs.jmedchem.6b01270 – ident: e_1_2_10_22_1 doi: 10.1038/nmeth.2172 – ident: e_1_2_10_13_1 doi: 10.1186/1476-4598-9-140 – ident: e_1_2_10_29_1 doi: 10.1006/bbrc.1996.0127 – ident: e_1_2_10_34_1 doi: 10.1194/jlr.P071803 – ident: e_1_2_10_19_1 doi: 10.1016/S1388-1981(02)00134-8 – volume: 57 start-page: 2516 year: 1997 ident: e_1_2_10_10_1 article-title: Expression and transcriptional regulation of the pd‐ialpha/autotaxin gene in neuroblastoma publication-title: Cancer Res – ident: e_1_2_10_6_1 doi: 10.1007/s10555-011-9319-7 – ident: e_1_2_10_14_1 doi: 10.1016/j.canlet.2014.10.001 – ident: e_1_2_10_31_1 doi: 10.1038/nsmb.1980 – ident: e_1_2_10_25_1 doi: 10.1074/jbc.274.16.11053 – ident: e_1_2_10_4_1 doi: 10.1016/S0021-9258(18)45911-X – ident: e_1_2_10_36_1 doi: 10.5551/jat.25650 – ident: e_1_2_10_28_1 doi: 10.1371/journal.pone.0130074 – ident: e_1_2_10_27_1 doi: 10.1016/j.cca.2007.10.005 – ident: e_1_2_10_3_1 doi: 10.1093/jb/mvu077 – ident: e_1_2_10_9_1 doi: 10.1023/A:1020950420196 – ident: e_1_2_10_18_1 doi: 10.1136/bjo.2007.116947 – ident: e_1_2_10_20_1 doi: 10.1074/jbc.M206812200 – ident: e_1_2_10_2_1 doi: 10.1083/jcb.200204026 – ident: e_1_2_10_26_1 doi: 10.1016/j.cca.2010.04.006 – ident: e_1_2_10_7_1 doi: 10.1016/j.bbalip.2012.08.015 |
| SSID | ssj0029510 |
| Score | 2.2674608 |
| Snippet | Autotaxin (ATX), a producing enzyme for lysophosphatidic acids, was first identified from the medium of a melanoma cell line and has been considered to be one... Autotaxin ( ATX ), a producing enzyme for lysophosphatidic acids, was first identified from the medium of a melanoma cell line and has been considered to be... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 571 |
| SubjectTerms | Acids autotaxin Enzymes Isoforms lysophosphatidic acids lysophosphatidylserine Melanoma Phosphatidylserine phosphatidylserine‐specific phospholipase A1 Phospholipase A1 Serum levels |
| Title | Association between serum autotaxin or phosphatidylserine‐specific phospholipase A1 levels and melanoma |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2F1346-8138.14278 https://www.ncbi.nlm.nih.gov/pubmed/29500864 https://www.proquest.com/docview/2030526602 https://www.proquest.com/docview/2010373384 |
| Volume | 45 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 0385-2407 databaseCode: DR2 dateStart: 20060101 customDbUrl: isFulltext: true eissn: 1346-8138 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029510 providerName: Wiley-Blackwell |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEA7iQbz4fqwvInjw0qVtsm16FN1FBD2IgreSJy5222XbgnryJ_gb_SVm-sIHIuKtkAxNM4_MdL6ZIHTkM0Ui6WrHsEg61FNW5wRVjrIE2ieUiBptcRWc39KLu0GLJoRamLo_RPfDDTSjsteg4FzkH5TcIzRwmEeYVXY_hHJfjwRVUHXdNZDywX-o8ghsAHmEsGnuA1ieL_Sfz6VvzuZn37U6fEbLSLTLrjEnD_2yEH35_KWj47--awUtNa4pPqllaRXN6XQNLVw2yfd1NP7AStzgu7CV4HKCeVlkBX8cpzib4el9lk_v7TT1lORVdeHbyytUdAIqqRnNkvHUnp_4xMMJwJZyzFOFJzrhaTbhG-h2NLw5PXeamxocSQOPOVpSKFkNiGY61JwSZvyBb4SBSlsDVxdSokwQeUwbwmzEJ4wJCDhHYaSla8gmmk-zVG8jrEJOjRtIl4aKUhFB5TC1lkVaw2SYCHuo3_Iplk0bc7hNI4nbcAY2MIYNjKsN7KHjjmBad_D4eepey_i4UeU89sEkWjfG9XvosBu2SgiZFZ7qrIQ5UG5po33aQ1u1wHTvsjIIcaMdqdn-2yLii7Nh9bDzV4JdtGgXwmo45h6aL2al3rcuUyEOKq14B5vgCcA |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9tAEB4VKpVeaEsfpKV0kThwcWR7N_b6iFpQSkkOVSJxs-x9iKiOHRFbAk78hP7G_pLO2I4VqKqq4mZpd-31zmO_2XkswKEvNY-UaxwrI-UIT6PMpUI7GgcYnwueNtEW42A4FWcXg4u1XJimPkR34EaSUetrEnA6kF6Tco-LwJEelyjtfig34KkI0FohYPS9KyHlE4KoPQlyQJ6EsC3vQ9E8D15wf2f6A27eR6_19nP6AtRq4k3UyY9-VaZ9dfugpuPj_uwlbLfolB037PQKnph8B56NWv_7a5itUZO1IV4Mmbias6QqizK5nuWsuGKLy2K5uMRu-iZb1gmGv-5-UlInBSa1rUU2W-AWyo49llHk0pIluWZzkyV5MU_ewPT0ZPJ56LSXNThKBJ50jBKUtRpwI01oEsGl9Qe-TS0l21q6vVBwbYPIk8ZyiUZfam3ACR-FkVGu5W9hMy9yswtMh4mwbqBcEWoh0oiShwUqF4W6yco07EF_RahYtZXM6UKNLF5ZNLSAMS1gXC9gD466AYumiMffu-6tKB-30ryMfdKKiGRcvwcHXTPKITlXktwUFfWhjEs0-EUP3jUc030LmZBMR2xp6P6vScRnX07qh_f_O-ATbA0no_P4_Ov42wd4jpOSTXTmHmyWV5X5iAiqTPdrEfkNVAIN4Q |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NatwwEB6aFEIu_U_rNm1UyCEXL7Yl2_IxdLOkSbuUkoW9GVs_7BKvbWIb2p76CH3GPkk1ttfspoRScjNIWms1-kYznm9GAMcelzQSjrI1j4TNXGkwlzJpSzNAeZTRtGNbTIPzGbuY-_ONXJiuPsTwwQ2R0eprBLgqpd5AuUtZYHOXcoN2L-Q78JD5EUda3_jrUELKQwuijSRwHyMJYV_eB9k8t35g-2T6y9zctl7b42fyGMR64h3r5HrU1OlI_LhV0_F-_-wJPOqtU3Labaen8EDlz2Dvcx9_fw7LDWmSnuJFzCZuViRp6qJOvi1zUtyQclFU5cJ0k9-zqk0w_P3zFyZ1IjGpby2yZWmOUHLqkgyZSxVJcklWKkvyYpW8gNnk7OrDud1f1mALFrjcVoJh1mpAFVehShjl2vM9nWpMttV4eyGjUgeRy5Wm3Dh9qdYBRfsojJRwND2A3bzI1SsgMkyYdgLhsFAylkaYPMyMchFGN2mehhaM1oKKRV_JHC_UyOK1R4MLGOMCxu0CWnAyDCi7Ih53dz1cSz7u0VzFHmpFY8k4ngXvh2aDQwyuJLkqGuyDGZfG4WcWvOx2zPAuswnRdTQtndz_NYn4YnzWPrz-3wFHsPdlPIk_fZxevoF9MyfekTMPYbe-adRbY0DV6bsWIX8A5wENZQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+serum+autotaxin+or+phosphatidylserine%E2%80%90specific+phospholipase+A1+levels+and+melanoma&rft.jtitle=Journal+of+dermatology&rft.au=Kurano%2C+Makoto&rft.au=Miyagaki%2C+Tomomitsu&rft.au=Miyagawa%2C+Takuya&rft.au=Igarashi%2C+Koji&rft.date=2018-05-01&rft.issn=0385-2407&rft.eissn=1346-8138&rft.volume=45&rft.issue=5&rft.spage=571&rft.epage=579&rft_id=info:doi/10.1111%2F1346-8138.14278&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_1346_8138_14278 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0385-2407&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0385-2407&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0385-2407&client=summon |